226 related articles for article (PubMed ID: 32199621)
1. Tranilast induces MiR-200c expression through blockade of RelA/p65 activity in leiomyoma smooth muscle cells.
Chuang TD; Rehan A; Khorram O
Fertil Steril; 2020 Jun; 113(6):1308-1318. PubMed ID: 32199621
[TBL] [Abstract][Full Text] [Related]
2. miR-200c regulates IL8 expression by targeting IKBKB: a potential mediator of inflammation in leiomyoma pathogenesis.
Chuang TD; Khorram O
PLoS One; 2014; 9(4):e95370. PubMed ID: 24755559
[TBL] [Abstract][Full Text] [Related]
3. Tranilast Inhibits Genes Functionally Involved in Cell Proliferation, Fibrosis, and Epigenetic Regulation and Epigenetically Induces miR-29c Expression in Leiomyoma Cells.
Chuang TD; Khorram O
Reprod Sci; 2017 Sep; 24(9):1253-1263. PubMed ID: 28114878
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying aberrant expression of miR-29c in uterine leiomyoma.
Chuang TD; Khorram O
Fertil Steril; 2016 Jan; 105(1):236-45.e1. PubMed ID: 26453978
[TBL] [Abstract][Full Text] [Related]
5. Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells.
Islam MS; Protic O; Ciavattini A; Giannubilo SR; Tranquilli AL; Catherino WH; Castellucci M; Ciarmela P
Fertil Steril; 2014 Aug; 102(2):597-606. PubMed ID: 24934492
[TBL] [Abstract][Full Text] [Related]
6. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
[TBL] [Abstract][Full Text] [Related]
7. Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis.
Chuang TD; Rehan A; Khorram O
Fertil Steril; 2021 Jan; 115(1):238-247. PubMed ID: 33070965
[TBL] [Abstract][Full Text] [Related]
8. The regulatory function of miR-200c on inflammatory and cell-cycle associated genes in SK-LMS-1, a leiomyosarcoma cell line.
Chuang TD; Ho M; Khorram O
Reprod Sci; 2015 May; 22(5):563-71. PubMed ID: 25305131
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between miR-29c and transforming growth factor-β3 is mediated by an epigenetic mechanism in leiomyoma.
Chuang TD; Khorram O
Fertil Steril; 2019 Dec; 112(6):1180-1189. PubMed ID: 31843095
[TBL] [Abstract][Full Text] [Related]
10. Tranilast inhibits the proliferation of uterine leiomyoma cells in vitro through G1 arrest associated with the induction of p21(waf1) and p53.
Shime H; Kariya M; Orii A; Momma C; Kanamori T; Fukuhara K; Kusakari T; Tsuruta Y; Takakura K; Nikaido T; Fujii S
J Clin Endocrinol Metab; 2002 Dec; 87(12):5610-7. PubMed ID: 12466360
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Cell Cycle Regulatory Proteins by MicroRNAs in Uterine Leiomyoma.
Chuang TD; Khorram O
Reprod Sci; 2019 Feb; 26(2):250-258. PubMed ID: 29642801
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids.
Pan Q; Luo X; Chegini N
J Cell Mol Med; 2008; 12(1):227-40. PubMed ID: 18182067
[TBL] [Abstract][Full Text] [Related]
13. miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.
Chuang TD; Panda H; Luo X; Chegini N
Endocr Relat Cancer; 2012 Aug; 19(4):541-56. PubMed ID: 22685266
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
Ding L; Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
[TBL] [Abstract][Full Text] [Related]
15. miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.
Chuang TD; Luo X; Panda H; Chegini N
Mol Endocrinol; 2012 Jun; 26(6):1028-42. PubMed ID: 22556343
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle.
Zhou Y; Ren Y; Cui L; Li Z; Zhu Y; Lin W; Wang Y
Am J Obstet Gynecol; 2014 Nov; 211(5):496.e1-496.e13. PubMed ID: 24909339
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of G-protein-coupled estrogen receptor-30 in human myometrial and uterine leiomyoma smooth muscle.
Tian R; Wang Z; Shi Z; Li D; Wang Y; Zhu Y; Lin W; Gui Y; Zheng XL
Fertil Steril; 2013 Jan; 99(1):256-263.e3. PubMed ID: 23043685
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/β-catenin pathway.
Corachán A; Ferrero H; Aguilar A; Garcia N; Monleon J; Faus A; Cervelló I; Pellicer A
Fertil Steril; 2019 Feb; 111(2):397-407. PubMed ID: 30458994
[TBL] [Abstract][Full Text] [Related]
19. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells.
Luo X; Ding L; Chegini N
Mol Hum Reprod; 2006 Apr; 12(4):245-56. PubMed ID: 16571622
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of tumor necrosis factor-α on matrix metalloproteinase-2 expression in human myometrial and uterine leiomyoma smooth muscle cells.
Wang Y; Feng G; Wang J; Zhou Y; Liu Y; Shi Y; Zhu Y; Lin W; Xu Y; Li Z
Hum Reprod; 2015 Jan; 30(1):61-70. PubMed ID: 25398968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
